Bristol-Myers Squibb Company (BMY)

BMY (NYSE:Drugs) EQUITY
$56.42
pos +0.00
+0.00%
Today's Range: 56.41 - 56.94 | BMY Avg Daily Volume: 7,285,500
Last Update: 08/18/17 - 4:01 PM EDT
Volume: 0
YTD Performance: -3.46%
Open: $0.00
Previous Close: $56.77
52 Week Range: $46.01 - $60.45
Oustanding Shares: 1,639,926,446
Market Cap: 93,098,624,339
6-Month Chart
TheStreet Ratings Grade for BMY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 5 5 5 6
Moderate Buy 1 1 1 1
Hold 6 6 6 6
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.31 2.31 2.31 2.21
Latest Dividend: 0.39
Latest Dividend Yield: 2.75%
Dividend Ex-Date: 07/05/17
Price Earnings Ratio: 20.72
Price Earnings Comparisons:
BMY Sector Avg. S&P 500
20.72 20.60 35.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
4.91% -3.85% 12.86%
GROWTH 12 Mo 3 Yr CAGR
Revenue 17.30 0.20 0.06
Net Income 176.30 0.80 0.20
EPS 184.90 0.70 0.19
Earnings for BMY:
EBITDA 5.01B
Revenue 19.43B
Average Earnings Estimates
Qtr (09/17) Qtr (12/17) FY (12/17) FY (12/18)
Average Estimate $0.75 $0.64 $2.97 $3.08
Number of Analysts 8 7 11 11
High Estimate $0.78 $0.68 $3.00 $3.23
Low Estimate $0.70 $0.60 $2.90 $2.77
Prior Year $0.77 $0.63 $2.83 $2.97
Growth Rate (Year over Year) -2.60% 1.81% 4.79% 3.80%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
What do you get from participation with the president, if the president doesn't represent the country's values?

A Roundup of My Open Positions Real Money Pro($)

Buying back Square puts and changing my trade on Target.

Capturing Profits on AIG Real Money Pro($)

Let's roll with the sure thing and not wait for expiry.
Move over, Helene, I'm getting in on what appears to be a breakout.
I've heard all of the bearish arguments, but I don't believe them.
The trade is the out-of-the-money, bullishly biased vertical call spread expiring in August.
The FAANG stocks will underperform, banks will do well and biotech merger action will pick up.
The FAANG stocks will underperform, banks will do well and biotech merger action will pick up.
It just isn't as useful or descriptive right now.
A rotation that started as the minor chord of the rotational symphony and is now the major one.

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.